Skip to content

Construction and application of collaborative risk prediction model of Chinese and Western medicine for diabetes based on large model

Construction and application of collaborative risk prediction model of Chinese and Western medicine for diabetes based on large model

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2026000729
Enrollment
Unknown
Registered
2026-03-25
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

The subjects were divided into a control group and a case group based on the outcome.:I am observing.

Sponsors

Peking Union Medical College, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients voluntarily participate in this study and sign the informed consent form. 2. Age between 18-80 years old. 3. Clinically diagnosed with prediabetes and high-risk population for diabetes. Prediabetes diagnosis: Based on the diagnostic criteria of the World Health Organization (WHO) in 1999. 2) High-risk population for diabetes: Based on the criteria of the "Chinese Guidelines for Diabetes Prevention and Treatment (2024 Edition)".

Exclusion criteria

Exclusion criteria: 1. = 18 or = 80 years old 2. Individuals with a history of diabetes or those taking antidiabetic medications 3. Pregnant or breastfeeding women 4. Individuals with neurological disorders 5. Individuals with unclear speech, unable to communicate normally, or unable to complete the questionnaire 6. Individuals with severe cerebral, cardiac, or vascular diseases, such as cerebral hemorrhage, myocardial infarction, aortic aneurysm, or arteriosclerotic diseases 7. Individuals unable to communicate with clinical staff or unwilling to participate in the questionnaire survey and follow-up

Design outcomes

Primary

MeasureTime frame
Blood Glucose;HbA1c,Glycated Hemoglobin A1c;

Secondary

MeasureTime frame
TG,Triglycerides;TC,Total Cholesterol; H-DLC,High-Density Lipoprotein Cholesterol; L-DLC,Low-Density Lipoprotein Cholesterol;GGT,Gamma-Glutamyl Transferase;ALP,Alkaline Phosphatase;TBil,Total Bilirubin; ALT,Alanine Aminotransferase;AST,Aspartate Aminotransferase; Cr,Serum Creatinine ; BUN,Blood Urea Nitrogen; UA,Uric Acid;

Countries

China

Contacts

Public ContactWu qunli

Peking Union Medical College, Chinese Academy of Medical Sciences

chinlie@163.com13611130305

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026